Thursday, November 14, 2013

Nutrastar International, Inc. (NUIN) Posts Strong Sales, Earnings Growth for Q3, Nine-Month Periods

Nutrastar International, a China-based producer of premium branded consumer products, health beverages, and organic and specialty foods, reports its financial results for the three and nine months ended September 30, 2013.

Revenues for the quarter increased 44.4% to $10.9 million, as compared to $7.5 million reported in the comparable quarter of 2012.

Net income increased 54.4% to $5.7 million, or $0.36 per share, compared to net income of $3.7 million, or $0.34 per share, reported in the year ago period.

For the nine months ended September 30, 2013, Nutrastar reports revenues of $30.2 million, a 23.5% increase compared to $24.4 million in the comparable nine months of 2012.

Net income was $15.1 million, an increase of $30.7 million, or $0.94 per share, as compared to $11.6 million, or $0.89 per share, in the comparable nine months of last year.

Nutrastar CEO Lianyun Han noted contributing factors to the strong quarterly and nine-month performance.

“With the production means necessary to expand our market, we are focused on further extending our brand awareness and product offering to better and more comprehensively serve our customers,” Han stated in the news release. “Prior launched marketing campaigns are working to promote the health benefits of our premium consumer products, especially our on-the-go functional health beverage and instant soluble drink. We also began testing sales of our instant soluble drink at the Bao Feng specialty drug store in Harbin for an initial trial period of up to six months that began this month. … Depending on how sales do in the trial store, this may or may not be a channel for us moving forward. On the new product front, we have started developing Cordyceps capsules and tablets, designed to complement our current premium consumer product offering and cater to our everyday customer looking for an on-the-go health supplement similar to other vitamin-type supplements. It’s estimated that the product development process for both capsules and tablets will take approximately 12 — 18 months to complete.”

Han said the company is on track with previously issued guidance for full-year 2013.

“With consumer demand for our premium products remaining strong and persistent, particularly among the wealthier and aging population, we are quite confident in our ability to meet our full year revenue guidance and continue to grow thereafter,” said Han. “We look forward to updating our shareholders and the investment community on our progress in these areas and more in the time ahead.”

For more information visit www.nutrastarintl.com

About MissionIR 

MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.

Sign up for “The Mission Report” at www.MissionIR.com

Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html